Introduction The omission of the immunohistochemical proliferation marker Ki-67 labelling index (henceforth. simply Ki-67) from the 2015 WHO classification system of pulmonary neuroendocrine tumours (Lung-NETs) as a prognostic and grading criterion remains controversial. This systematic review along with meta-analysis will be conducted to assess the prognostic/grading utility of Ki-67... https://www.wallascemercantileshops.shop/product-category/catch/
The utility of Ki-67 as a prognostic biomarker in pulmonary neuroendocrine tumours: protocol for a systematic review and meta-analysis
Internet - 1 minute ago vqdyrkuzu0cw59Web Directory Categories
Web Directory Search
New Site Listings